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Unique Collaborations for Quality Improvement in Vascular SurgeryTwenty-two years ago, a few enthusiastic pioneers met in
Lisbon and laid the foundation for VASCUNET, an open-
minded cross border collaboration of European and Aus-
tralasian vascular surgeons dedicated to vascular health
service research and quality improvement (www.vascunet.
org). This was before many important innovations in digi-
tal communication and data acquisition, when less than
50% of data were stored using digital technologies.1 Since
then, the digital revolution and rapid innovation in health-
care has led to the collection and analysis of “big data”,
which has become an important tool in modern medicine.2
Over the years, more than 25 joint publications of VASCU-
NET have been published in the European Journal of
Vascular and Endovascular Surgery and in the Journal of
Vascular Surgery. Hereby, VASCUNET was able to contribute
to the high quality of the two leading journals in vascular
surgery and spread the message to a global audience. In
addition, more than 50 international meetings have been
held by the European Society for Vascular Surgery (ESVS)
VASCUNET quality improvement network, illuminating the
fact that vascular surgeons can improve patient safety
without borders.3
Meanwhile, in the United States, the Vascular Study
Group of New England (VSGNE) was established in 2003.4
The VSGNE grew rapidly and served as an example for
the development of other regional quality groups, which
culminated in the formation of the Society for Vascular
Surgery (SVS) Vascular Quality Initiative (VQI) in 2011. The
VQI is an international organisation (including Canada and
Singapore) that consists of 18 regional groups and has over
500 000 patients in the database.5 To date, more than 230
peer reviewed publications have been published from the
SVS VQI, and all 18 regional quality groups meet bi-annually
to review their data and develop quality initiatives.
In 2014, the International Consortium of Vascular Regis-
tries (ICVR) was founded as an amalgamation of VASCUNET
and SVS VQI to conduct quality improvement projects in
vascular surgery using real world data from clinical registries
and administrative data sources.6 Owing to this global
expansion, countries from South America and Asia were
introduced to the research network. To date, members and
interested potential members from more than 30 different
countries join the two semi-annual meetings (alternating
between Europe and the United States). VASCUNET, VQI,1078-5884/ 2019 European Society for Vascular Surgery. Published by
Elsevier B.V. All rights reserved.
https://doi.org/10.1016/j.ejvs.2019.07.023and ICVR continue to welcome further development and
involvement of new registries in the international collabo-
ration. Just in the past year, vascular registries in Portugal,
Luxembourg, Serbia, and Greece have joined VASCUNET,
and others are currently considering participation.
Although the progress in international quality improve-
ment is impressive, many challenges remain and there is
much room for further improvement. For instance, the
latest VASCUNET report on lower limb amputations
involved a population base of 259 million inhabitants from
Europe and Australasia, but more than 500 million Euro-
peans were not included.7 Nevertheless, the results of the
amputation report recently revealed wide variation be-
tween the European and Australasian healthcare systems,
leading to a political debate in Hungary about the necessity
for vascular infrastructure to decrease the high incidence of
major amputations.
Similarly, 10 years ago the ﬁrst VASCUNET report on
abdominal aortic aneurysms (AAAs) demonstrated dispa-
rate outcomes in the United Kingdom compared with
eight other countries, providing a focus for quality
improvement efforts.8 During the ensuing four years, the
UK Vascular Services Quality Improvement Programme
(VSQIP) took note of these ﬁndings and was able to
dramatically decrease mortality after elective AAA repair
from 7.5% to 2.4%, emphasising the power of feedback
and benchmarking.
In the United States, all centres enrolled in the VQI
receive regular reports comparing relevant outcomes with
regional and national colleagues. Additionally, VQI centres
receive biannual “Centre Opportunity Proﬁles for Improve-
ment” reports, which are a powerful tool that translates
procedural results into actionable centre level data that can
be used to improve patient care. In addition to innumerable
ongoing regional and local quality initiatives in VQI centres,
there are also ongoing national quality initiatives, including
increasing the post-operative prescription of medications
known to increase long term survival (statin and antiplatelet
therapy) and improvement in long term follow up of
endovascular AAA with appropriate imaging.
Despite the clear advantages of participation in VASCU-
NET and ICVR, some countries have not elected to join
these quality improvement efforts. Obstacles to participa-
tion include the difﬁculties with developing a data privacy
compliant national registry and challenges with accessing
administrative data. These issues have become particularly
problematic since the European Union (EU) General Data
Privacy Regulation was enacted. Importantly, the ICVR can
Editorial 793support the process of implementing data privacy
compliant solutions, and collaborating with other countries
can provide important resources for developing a compliant
registry.9,10
VASCUNET, VQI, and ICVR are far more than a group of
registry representatives or real world evidence experts. In
the past year, 15 project proposals have been meticulously
discussed by the ICVR group. Important projects have been
completed by methodological group collaboration to over-
come challenges that are inherent in registry research,
including limitations associated with retrospective cohort
studies (e.g. propensity score matching or instrumental
variables methods). Another important scope of this global
collaboration is the development of device evaluation
methods to accomplish the requirements of the EU Medical
Device Regulations, which will be increasingly important
given recent regulatory changes in Europe.
To date, ICVR projects have focused on evaluation of
variation and international benchmarking of vascular prac-
tice (e.g. treatment of peripheral arterial occlusive disease,
aortic aneurysms, and carotid stenosis). Discussions are
ongoing to increase the impact of the collaborations by
developing quality initiatives based on identiﬁed best prac-
tices with subsequent prospective monitoring of adherence
to societal guidelines. An example would be monitoring (e.g.
statin/antiplatelet therapy) for patients with symptomatic
peripheral arterial disease. Another impactful project of the
ICVR that is under discussion is monitoring of long term
outcomes of paclitaxel coated or other high risk devices
using international data. Against the backdrop of an ongoing
debate concerning the validity of results from randomised
controlled trials, real world evidence from registries can
provide clarity in these discussions. Lastly, ICVR offers the
unique advantages of big data, the increased power from
the large n of combining multiple registries. There is po-
tential for large scale analysis of rare events and conditions
such as vascular malignancies and long term monitoring of
outcomes. Deﬁned project proposals initiated by researchers
are welcomed. This rapidly growing global collaboration
needs your support to improve the data privacy compliant
real world evidence, and additional international collabora-
tors are welcomed.
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